BANGALORE (Dow Jones) – The Indian pharmaceutical company Cipla has a generic of the kidney cancer drug "Nexavar" by Bayer in India put on the market. The generic name Sorafenib "tosylates" about one tenth of the price of Bayer cost of 280,000 INR (equivalent to about € 4,700) for a monthly treatment said Joint Managing Director Amar Lulla Dow Jones Newswires on Thursday. Bayer and Cipla are due to the drug in a Litigation.
Web sites: www.bayer.com www.cipla.com -By Rumman Ahmed, Dow Jones Newswires +49 (0) 69 29725 130, unternehmen.de @ dowjones.com DJG / DJN / ebb / has Visit our website http://www.dowjones.de
(END) Dow Jones Newswires
April 08, 2010 06:18 ET (10:18 GMT)
Copyright (c) 2010 Dow Jones & Company, Inc